Study of Fruquintinib in Patients With Metastatic Colorectal Cancer

NCT02196688 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: fruquintinib
DRUG: placebo

Sponsor

Hutchison Medipharma Limited

Collaborators

[object Object]
[object Object]